It is not known whether the presence of BCL-6 is related to the difference in morphology between AITL and TFH-PTCL-NOS, or if it has a role in a difference in the etiopathogenesis of these two tumor subgroups. The gene discussed is BCL6; the disease is angioimmunoblastic T-cell lymphoma.